Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Manufacturing & Bioprocessing
Proactive Approaches to Cell Culture Media and Process Control Strategies
Merck invests $25 million in a Kansas cell culture media plant, aiming to meet rising demand for advanced therapeutics while aligning with sustainability goals.
Antibody & Protein Engineering
The Current Landscape of ADC Approvals and Market Trends: Q&A With Mahendra Deonarain, CEO of Antikor Biopharma
While a recent spike in ADC approvals may not last forever, Antikor Biopharma’s Mahendra Deonarain asserts that antibody-drug conjugates are here to stay.
Manufacturing & Bioprocessing
In Conversation With… Sophie Mountcastle, Network Manager, Innovation Hubs for Gene Therapies
Here, we discuss the crucial role of a collaborative network for gene therapy development across the UK and some of the successes seen to date.
Stem Cell Therapy
Comparing Allogeneic and Autologous Stem Cell Transplantation Approaches
While both allogeneic and autologous cell therapies have seen a recent boom, the two approaches differ in terms of scale and customisation.
Manufacturing & Bioprocessing
Improving Control Strategies for Bioprocessing & Cell Culture
Discover advanced monitoring, environmental controls, mathematical models, PAT tools, and sensor technologies shaping the future of biopharmaceuticals
Antibody & Protein Engineering
Introducing the Development and Clinical Landscape of Bi and Multispecific Antibodies
While bispecific antibodies target two specific entities, multispecific antibodies can target more than two. The use of these engineered antibodies offers the potential for enhanced therapeutic strategies by simultaneously addressing multiple aspects of a disease.
Drug Discovery & Development
Immunostimulatory Oncolytic Viruses: Interview with Angelica Loskog, CEO, Lokon Pharma
Diving deep into Lokon Pharma's immunostimulatory oncolytic virus programme. Learn about their LOAd platform, transition to the clinic, and more.
Biomarkers & Precision Medicine
Oncolytic Virus Immunotherapy: A Revolutionary Approach in Immuno-Oncology
Explore the cutting-edge of oncolytic virus immunotherapy in immuno-oncology: the viruses revolutionizing cancer treatment and the promise they hold for future therapies.
Stem Cell Therapy
Applications of Stem Cells in Personalised Medicine
Novel applications of stem cells drive personalized medicine, tailoring treatments to each patient's unique profile. Explore groundbreaking applications for more effective, individualized therapies.
Antibody & Protein Engineering
Cytokines and Immunocytokines in Therapeutic Approaches
Advancements in cytokine understanding and synthetic immunology enable precise immune modulation, particularly in cancer treatment. However, challenges like short half-lives and side effects impact their wider clinical application.
Tumour Microenvironment
The Therapeutic Modulation of Cytokines with Pierre Ferré, VP of Pre-Clinical Development, Compugen
Compugen's candidate therapeutic, COM503, targets interleukin-18 binding protein to unleash interleukin-18's immunostimulatory power.
Manufacturing & Bioprocessing